Latest Alaunos Therapeutics News & Updates

See the latest news and media coverage for Alaunos Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alaunos Therapeutics

Biotechnology company developing obesity and metabolic disorder treatments

alaunos.com
Headquarters
Houston, United States
Company type
Public company
Number of employees
10–50
Industry
Pharmaceuticals

Last updated

Latest news about Alaunos Therapeutics

Company announcements

Alaunos Therapeutics

Alaunos Therapeutics reports Q3 2022 financial results and clinical data

The company reported a net loss of $8.9 million, collaboration revenue of $2.9 million, and presented early TCR-T trial data showing objective responses in solid tumors.

Unlock all announcements with a

Media coverage

ICLG

Gibson Dunn steers biotech company acquisition | ICLG

Waltham, Massachusetts-based Velaris Therapeutics, based on assets discovered by Paragon Laboratories, is a biotechnology company with a pipeline of potential therapies for treating pulmonary hypertension...

StreetInsider

Alaunos Therapeutics (TCRT) Reports Q3, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

Clinical Data from TCR-T Library Phase 1/2 Trial: Eight patients were treated and evaluated in the Company's TCR-T Library Phase 1/2 Trial. Patients with pancreatic...

Unlock all articles with a

Never miss news about Alaunos Therapeutics

Track Alaunos Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alaunos Therapeutics competitors & trending companies

Browse news for competitors to Alaunos Therapeutics and other trending companies.